Aro Biotherapeutics develops tissue-targeted genetic medicines using Centyrins, a proprietary technology, to address complex diseases.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Aro Biotherapeutics — Funding & Investors." VCBacked, November 28, 2023, https://www.vcbacked.co/company/aro-biotherapeutics. Accessed June 17, 2026.
VCBacked. (2023). Aro Biotherapeutics — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/aro-biotherapeutics
{{cite web |title=Aro Biotherapeutics — Funding & Investors |url=https://www.vcbacked.co/company/aro-biotherapeutics |website=VCBacked |access-date=June 17, 2026}}Profile data sourced and verified per the VCBacked methodology. Last funding round dated .